ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

Leukemia Society Program In Transitional Research.

January 14, 2000

NSAIDs Cut Oral Cancer Risk But Raise Smokers’ Heart Risk

October 28, 2005

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

February 2, 2007

St. Jude Considers Relocating to Washington U.

August 9, 1985

Upton May Leave NCI Soon, Newell Accepts Post At M.D. Anderson to Head Cancer Prevention

August 17, 1979